Rosaria Giordano

Dr. Rosaria Giordano


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
LSL. Sensebã©
L. Sensebã©
MKM. Krampera
M. Krampera
HSH. Schrezenmeier
H. Schrezenmeier
PBP. Bourin
P. Bourin
RGRosaria Giordano
Rosaria Giordano

1 July 2007 in Cell Transplantation
Verified
Journal Article
Open access
YTYvan Torrente
Yvan Torrente
MBM. Belicchi
M. Belicchi
CMC. Marchesi
C. Marchesi
Giuseppe D'AntonaGiuseppe D'Antona
Giuseppe D'Antona
FCF. Cogiamanian
F. Cogiamanian
NBN. Bresolin
N. Bresolin
Duchenne muscular dystrophy (DMD) is a lethal X-linked recessive muscle disease due to defect on the gene encoding dystrophin. The lack of a functional dystrophin in muscles results in the fragility of the muscle fiber membrane with progressive muscle weakness and premature death. There is no cure for DMD and current treatment options focus primarily on respiratory assistance, comfort care, and delaying the loss of ambulation. Recent works support the idea that stem cells can contribute to muscle repair as well as to replenishment of the satellite cell pool. Here we tested the safety of autologous transplantation of muscle-derived CD133+ cells in eight boys with Duchenne muscular dystrophy in a 7-month, double-blind phase I clinical trial. Stem cell safety was tested by measuring muscle strength and evaluating muscle structures with MRI and histological analysis. Timed cardiac and pulmonary function tests were secondary outcome measures. No local or systemic side effects were observed in all treated DMD patients. Treated patients had an increased ratio of capillary per muscle fibers with a switch from slow to fast myosin-positive myofibers.

11 January 2013 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
Enrico RagniEnrico Ragni
Enrico Ragni
MVMariele Viganò
Mariele Viganò
PRPaolo Rebulla
Paolo Rebulla
RGRosaria Giordano
Rosaria Giordano
Lorenza LazzariLorenza Lazzari
Lorenza Lazzari
In the last years, mesenchymal stem cells (MSCs) have been identified as an attractive cell population in regenerative medicine. In view of future therapeutic applications, the study of specific differentiation‐related gene expression is a pivotal prerequisite to define the most appropriate MSC source for clinical translation. In this context, it is crucial to use stable housekeeping genes (HGs) for normalization of qRT‐PCR to obtain validated and comparable results. By our knowledge, an exhaustive validation study of HGs comparing MSCs from different sources under various differentiation conditions is still missing. In this pivotal study, we compared the expression levels of 12 genes (ACTB, Β2M, EF1alpha, GAPDH, GUSB, PPIA, RPL13A, RPLP0, TBP, UBC, YWHAZ and 18S rRNA) to assess their suitability as HGs in MSCs during adipogenic, osteogenic and chondrogenic differentiation. We demonstrated that many of the most popular HGs including 18S rRNA, B2M and ACTB were inadequate for normalization, whereas TBP/YWHAZ/GUSB were frequently identified among the best performers. Moreover, we showed the dramatic effects of suboptimal HGs choice on the quantification of cell differentiation markers, thus interfering with a reliable comparison of the lineage potential properties among various MSCs. Thus, in the emerging field of regenerative medicine, the identification of the most appropriate MSC source and cell line is so crucial for the treatment of patients that being inaccurate in the first step of the stem cell characterization can bring important consequences for the patients and for the promising potential of stem cell therapy.

1 July 2007 in Stem Cells
Verified
Journal Article
Open access
PDF file
SZStefano Zangrossi
Stefano Zangrossi
Mirko MarabeseMirko Marabese
Mirko Marabese
Massimo BrogginiMassimo Broggini
Massimo Broggini
RGRosaria Giordano
Rosaria Giordano
MDMarco D'ERasmo
Marco D'ERasmo
Lorenza LazzariLorenza Lazzari
Lorenza Lazzari
STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology. STEM CELLS welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. The journal covers all aspects of stem cells embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.

1 January 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
Francesco PetrellaFrancesco Petrella
Francesco Petrella
FAFabio Acocella
Fabio Acocella
MBMassimo Barberis
Massimo Barberis
MBMassimo Bellomi
Massimo Bellomi
SBStefano Brizzola
Stefano Brizzola
LSLorenzo Spaggiari
Lorenzo Spaggiari
Large-airway defects and tracheobronchial dehiscence after lung resection present a problem for clinicians because there are few effective methods of treatment.1 Bronchopleural fistula is a pathologic connection between the airway and the pleural space that may develop after lung resection. For many patients with empyema, the presence or absence of a fistula makes the difference between recovery, chronic illness, and death.2,3

20 August 2013 in Tissue Engineering Part C: Methods
Verified
Journal Article
Open access
EVElena Veronesi
Elena Veronesi
AMAlba Murgia
Alba Murgia
ACAnna Caselli
Anna Caselli
GGGiulia Grisendi
Giulia Grisendi
MPMaria Serena Piccinno
Maria Serena Piccinno
MDMassimo Dominici
Massimo Dominici
Successful preliminary studies have encouraged a more translational phase for stem cell research. Nevertheless, advances in the culture of human bone marrow-derived mesenchymal stromal/stem cells (hBM-MSC) and osteoconductive qualities of combined biomaterials can be undermined if necessary cell transportation procedures prove unviable. We aimed at evaluating the effect of transportation conditions on cell function, including the ability to form bone in vivo , using procedures suited to clinical application. hBM-MSC expanded in current Good Manufacturing Practice (cGMP) facilities (cGMP-hBM-MSC) to numbers suitable for therapy were transported overnight within syringes and subsequently tested for viability. Scaled-down experiments mimicking shipment for 18 h at 4°C tested the influence of three different clinical-grade transportation buffers (0.9% saline alone or with 4% human serum albumin [HSA] from two independent sources) compared with cell maintenance medium. Cell viability after shipment was >80% in all cases, enabling evaluation of (1) adhesion to plastic flasks and hydroxyapatite tricalcium phosphate osteoconductive biomaterial (HA/β-TCP 3D scaffold); (2) proliferation rate; (3) ex vivo osteogenic differentiation in contexts of 2D monolayers on plastic and 3D HA/β-TCP scaffolds; and (4) in vivo ectopic bone formation after subcutaneous implantation of cells with HA/β-TCP scaffold into NOD/SCID mice. Von Kossa staining was used to assess ex vivo osteogenic differentiation in 3D cultures, providing a quantifiable test of 3D biomineralization ex vivo as a rapid, cost-effective potency assay. Near-equivalent capacities for cell survival, proliferation, and osteogenic differentiation were found for all transportation buffers. Moreover, cGMP-hBM-MSC transported from a production facility under clinical-grade conditions of 4% HSA in 0.9% saline to a destination 18 h away showed prompt adhesion to HA/β-TCP 3D scaffold and subsequent in vivo bone formation. A successfully validated transportation protocol extends the applicability of fresh stem cells involving multicentric trials for regenerative medicine.